Chemours Reports Q4 Earnings; Misses EPS Expectations

Chemours Company reports Q4 earnings with an EPS of -$0.05, missing expectations. Analysts had projected $0.16 per share, which indicates a concerning performance for investors as the company faces declining revenue.

Date: 18-02-2025

AI Rating: 4

Earnings Per Share (EPS): The Chemours Company reported an EPS of -$0.05 for Q4, an improvement from -$0.12 in the same period last year. However, it still falls short of analysts' expectations of $0.16 per share, reflecting a negative trend.

Revenue Growth: Revenue for the quarter was $1.359 billion, slightly down from $1.368 billion the previous year. This indicates a decline in revenue growth, which is a concern for investors.

Net Income: The net income figure stands at -$8 million for Q4, compared to -$18 million year over year, showing some improvement but still negative.

The misses in EPS and revenue projections are likely to negatively impact investor sentiment, leading to volatility in Chemours' stock price.

Stocks: CC